The "Promise of Savings" is finally becoming a "Reality of the Balance Sheet" this year. In 2026, the US Biosimilars Market is on track to save the American healthcare system an estimated 54 billion dollars annually. Since the first biosimilar was launched in 2015, the cumulative savings have now surpassed 100 billion dollars, providing a much-needed "Safety Valve" for the rising costs of...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
china 
thai
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)